# Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antitumor-activity-of-rapamycin-in-a-phase-i-trial-for-patients-with-recurrent/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tim Cloughesy,Koji Yoshimoto,Phioanh L. Nghiemphu,Kevin R. Brown,Julie Dang,Shaojun Zhu,Teli Hsueh,Yinan Chen,Wei Wang,David Youngkin,Linda M. Liau,Neil A. Martin,Don Becker,Marvin Bergsneider,Albert Lai,Richard Green,Tom Oglesby,Michael Koleto,J.M. Trent,Steve Horvath,Paul S. Mischel,Ingo K. Mellinghoff,Charles L. Sawyers |
| Citations | 595 |
| DOI | 10.1371/journal.pmed.0050008 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0050008&type=printable |
| OpenAlex ID | https://openalex.org/W2116622644 |
| PMID | 18215105 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Phioanh L. Nghiemphu](https://scholariq.org/researchers/phioanh-l-nghiemphu/)
- [Marvin Bergsneider](https://scholariq.org/researchers/marvin-bergsneider/)

## Paper journal

- [PLoS Medicine](https://scholariq.org/journals/plos-medicine/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.